Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human GABARAPL1 ELISA Kit (AC2903)
Cat.#: ASET-1492
Specifications
Description Human GABARAPL1 ELISA Kit allows for the in vitro quantitative determination of human GABARAPL1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1589 Mouse Ki67 ELISA Kit (AC3000) Quantitative inquiry ASET-1497 Human Hyaluronan Synthase 2 ELISA Kit (AC2908) Quantitative inquiry ASET-1137 Rat SOX9 ELISA Kit (AC2548) Quantitative inquiry ASET-1320 Porcine Myelin Basic Protein ELISA Kit (AC2731) Quantitative inquiry ASET-1955 Rat Cannabinoid Receptor I ELISA Kit (AC3366) Quantitative inquiry ASET-2390 Human CCR5 ELISA Kit (AC3801) Quantitative inquiry ASET-1411 Human Plexin B1 ELISA Kit (AC2822) Quantitative inquiry ASET-1060 Mouse Homer1 ELISA Kit (AC2471) Quantitative inquiry ASET-1657 Rat Thyroid Hormone Receptor alpha ELISA Kit (AC3068) Quantitative inquiry ASET-1210 Malondialdehyde ELISA Kit (AC2621) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
We are committed to accelerating progress in stroke research and drug development.
Copyright © Ace Therapeutics. All rights reserved.0Inquiry Basket